4//SEC Filing
Portnoy Mark L. 4
Accession 0001193125-26-009068
CIK 0000862692other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 5:00 PM ET
Size
19.5 KB
Accession
0001193125-26-009068
Insider Transaction Report
Form 4
Portnoy Mark L.
DirectorCo-CEO10% Owner
Transactions
- Award
Stock Option
2026-01-07$3.89/sh+50,000$194,500→ 50,000 totalExercise: $3.89From: 2026-01-07Exp: 2031-01-07→ Common Stock (50,000 underlying) - Award
Stock Option
2026-01-07$3.89/sh+25,000$97,250→ 25,000 totalExercise: $3.89From: 2026-01-07Exp: 2031-01-07→ Common Stock (25,000 underlying)
Holdings
- 821,973
Common Stock
- 42,266(indirect: By 401(k))
Common Stock
- 71,529(indirect: By Partnership)
Common Stock
- 22,222
Stock Option
Exercise: $7.53From: 2019-08-30Exp: 2029-08-30→ Common stock (22,222 underlying) - 20,000
Stock Option
Exercise: $7.28From: 2019-12-20Exp: 2029-12-20→ Common Stock (20,000 underlying) - 100,000
Stock Option
Exercise: $12.27From: 2021-12-22Exp: 2028-12-22→ Common Stock (100,000 underlying) - 25,000
Stock Option
Exercise: $4.77From: 2023-01-03Exp: 2028-01-03→ Common Stock (25,000 underlying) - 25,000
Stock Option
Exercise: $4.30From: 2022-12-23Exp: 2027-12-23→ Common Stock (25,000 underlying) - 25,000
Stock Option
Exercise: $6.47From: 2023-12-22Exp: 2028-12-22→ Common Stock (25,000 underlying) - 25,000
Stock Option
Exercise: $8.08From: 2025-01-21Exp: 2030-01-21→ Common Stock (25,000 underlying)
Footnotes (7)
- [F1]Shares of common stock held by Capital Asset Fund #1 Limited Partnership, as to which Mark Portnoy may be deemed beneficial owner as its general partner.
- [F2]Stock options will vest immediately if the price of the Company's common stock reaches $25.00 per share during the seven-year option term.
- [F3]8,750 stock options vest upon issuance, 8,749 options vest on 1/2/2024, 21,000 options vest on 1/2/2025 and 11,501 options vest on 1/2/2026.
- [F4]Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025.
- [F5]Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027.
- [F6]The stock options were granted pursuant to the Cryo-Cell 2022 Stock Incentive Plan and an individual award agreement. The options are divided into three equal tranches, each subject to both time-based vesting and stock-price performance conditions. One tranche vests after the first anniversary of the grant date and upon the Company's common stock achieving an average closing price of at least $6 per share over 20 consecutive trading days. One tranche vests after the second anniversary and upon achieving an average closing price of at least $8 per share over 20 consecutive trading days. One tranche vests after the third anniversary and upon achieving an average closing price of at least $10 per share over 20 consecutive trading days, in each case subject to the reporting person's continued service to the Company.
- [F7]Stock options vest 1/3 upon issuance, 1/3 on January 7, 2027 and 1/3 on January 7, 2028.
Documents
Issuer
CRYO CELL INTERNATIONAL INC
CIK 0000862692
Entity typeother
Related Parties
1- filerCIK 0001529249
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 5:00 PM ET
- Size
- 19.5 KB